Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV Vaccines
Collaboration Aims To Advance Prophylactic Immunization In Developing Countries
April 11th, 2001
In continuing efforts to curb the global spread of AIDS, The International AIDS Vaccine Initiative (IAVI) and Therion Biologics will collaborate as new partners to develop prophylactic AIDS vaccines for developing countries, specifically India. The unique partnership brings together Therion's vaccine technology, IAVI's development capabilities, and Indian scientists focused in AIDS research. Under terms of the collaboration, IAVI will fully fund Therion's work in designing, engineering, and manufacturing a novel vaccine specific for the strain of HIV (subtype C) common to India. Pending necessary approvals from appropriate regulatory agencies,...
Source: Vaccine Weekly (2001-04-11)
|
